Clinical Trials Logo
  1. Home
  2. AMI
  3. NCT04485988
  4. Details
NCT04485988 Clinical Trial

Influence of Beta Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction

AMI Clinical Trial

Official title:
Influence of Beta Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04485988
Other study ID # 2020-06-25
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 1, 2015
Est. completion date July 2021

Study information
Verified date June 2021
Source Chongqing Medical University
Contact dongying zhang, doctor
Phone 86.27.8901.1596
Email zhangdongying@cqmu.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To understand the effect of beta blockers on the prognosis of patients with acute myocardial infarction with preserved ejection fraction.

Description:

The use of beta blockers is an important component of drug therapy for myocardial infarction, but in some exceptional cases, evidence-based evidence for their use is insufficient, and we seek to understand the prognostic impact of beta blockers on patients enrolled in long-term follow-up.

Recruitment information / eligibility
Status Recruiting
Enrollment 3000
Est. completion date July 2021
Est. primary completion date December 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Patients with acute myocardial infarction Exclusion Criteria: - Previous history of heart failure admission Killip class > I class cancer pregnant

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Beta blocker
Duration of medication

Locations
Country Name City State
China The First Affiliated Hospital of Chongqing Medical University Chongqing Chongqing

Sponsors (1)
Lead Sponsor Collaborator
Chongqing Medical University

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Death all-cause mortality The median time of 3 years
See also
  Status Clinical Trial Phase
Recruiting NCT02793934 - The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation
Recruiting NCT05122455 - Effects of Edoxaban on Platelet Aggregation Phase 2/Phase 3
Recruiting NCT05201274 - Baduanjin Sequential Therapy and Cardiac Function of AMI With Reduced EF After PCI N/A
Completed NCT00289237 - Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease N/A
Completed NCT00331578 - Multi-Center Registry Trial of EXCEL Biodegradable Polymer Drug-Eluting Stent Phase 4
Recruiting NCT05764057 - DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction Phase 3
Terminated NCT00670228 - Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction Phase 3